The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol.

OBJECTIVE: To investigate the characteristics of Hep-2 cell with multidrug resistance (MDR) induced by Taxol. STUDY DESIGN: Hep-2 cells were exposed in stepwise escalating concentration of Taxol to develop the resistant cell line-Hep-2T. Cell cycle distribution, apoptosis, and rhodamine accumulation were studied through flow cytometry. The MDR1 and MRP1 genes were detected through real-time quantitative RT-PCR, and the corresponding proteins were detected through Western blotting. RESULTS: The drug resistance of Hep-2T cells to Taxol, doxorubicin, gemcitabine, 5-FU, and cisplatin all increased. The percentage of G0/G1 phase and the antiapoptosis ability increased significantly compared with Hep-2 cells. Both MDR1 and MRP1 also increased at gene and protein level, though MDR1 was more prominent. CONCLUSION: More emphasis should be laid on MDR1/Pgp, the non-Pgp substrate chemotherapeutic agents, and the changes of cell cycle distribution to prevent MDR induced by Taxol. SIGNIFICANCE: These findings may provide theoretical support for the reverse of MDR.     

手助腹腔镜巨脾和胆囊联合切除术

目的 :总结手助的腹腔镜巨脾切除手术技术。方法 :用手助技术完成腹腔镜巨脾和胆囊联合切除术治疗 1例脾肿大、脾功能亢进伴胆囊结石患者。结果 :4 5h完成手术 ,术中出血较少。患者术后恢复良好。结论 :手助的腹腔镜巨脾和胆囊联合切除术操作安全 ,手术时间短 ,技术上完全可行     

50例冠心病某些生化基础观测的临床诊断意义

对５０例冠心病患者进行某些生化基础观测，发现冠心病肾阴虚与糖耐量减低有关，肾阳虚患者尿１７－羟低於正常；而冠心病标证有其生化基础，与甘油三酯增高有密切相关。     

血管内氧合器的研制

为了探索呼吸辅助的新方法，我们采用国产聚丙烯中空纤维，自行设计、制造模具，研制出一种血管内氧合器。该氧合器是一个小的、细长的可经单侧股静脉或颈静脉切开，置入腔静脉内的装置。氧合器有效长度４０ｃｍ，膜交换面积０．０９ｍ＾２。经负压调节通过血管内氧合器的氧流量，以防止纤维破裂造成的血管内气栓的危险。一根双腔导气管使气体经同一静脉切开部位循环，气体经内芯管流经血管内氧合器尖端，然后经中空纤维束流出。目前     

El Tor型霍乱弧菌L型的某些生物学性状

本研究主要对El Tor型霍乱弧菌(Vibrio cholerae biotvpe eltor,EVC)L型的某些生物学特性如生化反应、抗生素敏感性及超微结构等进行了探讨.研究发现EVC不稳定L型的生化性状与EVC流行株的非常相似,而稳定L型则变化很大.抗生素敏感性试验显示EVC稳定L型对某些作用于细胞壁的抗生素的敏感性减弱,而对大多数作用于蛋白质合成的抗生素的敏感性增强.与流行株相比,EVC稳定L型和不稳定L型的超微结构的改变很明显.此外,本文还讨论了产生这些改变的可能机制.     

原发性干燥综合征与人类组织相容性抗原—DRβ基因

原发性干燥综合征（ＰＳＳ）的病因未明，其中可能涉及遗传因素。用序列特异性引物聚合酶链反应（ＰＣＲ－ＳＳＰ）法对７０例ＰＳＳ患者和１３６名正常人进行人类组织相容性抗原（ＨＬＡ）－ＤＲβ基因分型。发现ＰＳＳ患者群体的ＨＬＡ－ＤＲ３、ＤＲ５２及ＤＲ２的基因频率明显高于正常对照组，而ＨＬＡ－ＤＲ５及ＤＲ９的基因频率则相反，提示ＰＳＳ的发病与ＤＲ３、ＤＲ５２及ＤＲ２呈正相关；而和ＤＲ９、ＤＲ５呈负相关。２个ＰＳＳ患者家族的姐妹与患者具有相同的遗传因素，且和ＰＳＳ患者群体测定的正相关基因相一致。ＰＳＳ患者的主要自身抗体（抗ＳＳＡ抗体及抗ＳＳＢ抗体）与ＨＬＡ－ＤＲ５２之间有明显的相关性，因而表明ＰＳＳ的发病和遗传因素有关。     

Population toxicokinetics of tetrachloroethylene

 In assessing the distribution and metabolism of toxic compounds in the body, measurements are not always feasible for ethical or technical reasons. Computer modeling offers a reasonable alternative, but the variability and complexity of biological systems pose unique challenges in model building and adjustment. Recent tools from population pharmacokinetics, Bayesian statistical inference, and physiological modeling can be brought together to solve these problems. As an example, we modeled the distribution and metabolism of tetrachloroethylene (PERC) in humans. We derive statistical distributions for the parameters of a physiological model of PERC, on the basis of data from Monster et al. (1979). The model adequately fits both prior physiological information and experimental data. An estimate of the relationship between PERC exposure and fraction metabolized is obtained. Our median population estimate for the fraction of inhaled tetrachloroethylene that is metabolized, at exposure levels exceeding current occupational standards, is 1.5% [95% confidence interval (0.52%, 4.1%)]. At levels approaching ambient inhalation exposure (0.001 ppm), the median estimate of the fraction metabolized is much higher, at 36% [95% confidence interval (15%, 58%)]. This disproportionality should be taken into account when deriving safe exposure limits for tetrachloroethylene and deserves to be verified by further experiments. Received: 20 April 1995/Accepted: 24 August 1995     

环丙沙星与氧氟沙星注射液治疗细菌性感染的疗效观察

以乳酸环丙沙星（ＣＰＬＸ）注射液和氧氟沙星（ＯＦＬＸ）注射液随机分组治疗各种细菌性感染４０例及４２例，并以注射用头孢噻肟钠（ＣＴＸ）治疗４９例作对照。三组平均年龄、体重、疗程及病情程度相比无显著性差异，具可比性。病种分布以消化道感染最多，共８１例，占总数的６１．８％。三组１３１例病人细菌阳性率为９４．７％。一疗程ＣＰＬＸ组、ＯＦＬＸ组、ＣＴＸ组治愈率分别为８７．２％、８３．３％、７１．４％，有效率     

颈椎后纵韧带骨化的治疗方法

从１９８３年８月至１９９１年３月，手术治疗６３例颈韧后纵韧带骨化（ＯＰＬＬ）的患者。手术方法包括前路椎间减压融合，椎体次全切除植骨融合、后路全椎板切除。单开门椎板成形椎管扩大手术、双开门椎板成形椎管扩大手术，及前后路两次手术。随诊６到９６个月，疗效为３９例代。１６例良，优良率８７．２％。本文讨论了前路椎间减压、椎体次全切除及后路椎板成形椎管扩大手术的方法。作者认为对ＯＰＬＬ伴广泛性椎管狭窄者以后路双开门椎板成形椎管扩大手术较为合理。     

世界生物技术药品市场的现状及展望

生物技术的迅速发展将导致一场新的药物革命。预计2000年世界生物技术药品的销售额将达500亿美元。美国、日本和西方工业化国家的制药公司对生物技术药品的开发非常重视。目前,人生长激素、红细胞生长素和人胰岛素在医药市场中占有重要位置,毫无疑问,二十一世纪的医药市场将是生物技术药品的时代。